Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine in Mild to Moderate Knee Osteoarthritis
NCT06960694Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jun 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levocarnitine in knee osteoarthritis (OA) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 8 weeks. Started Jun 2025; status: completed.
02
Drugs
levocarnitine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06960694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06960694.